zen3694,talazoparib,ceralasertib,olaparib
pfizer,astrazeneca,merck,zenith capital corporation
['talazoparib', 'ceralasertib', 'olaparib', 'tnbc', 'brca', 'zen-3694 ']
 "unity is strength? not always!"
- abs 1023: zen-3694 (bet-inhib) can sensitize brcawt tumors to talazoparib: orr in tnbc 32%, mpfs 17 wks
- abs 1024: olaparib + ceralasertib did not meet efficacy criteria: crr 17.1% and mpfs 4.3 mo #asco22 #bcareporter 